Loading...
Mean travel time to the nearest abortion facility rose from 27.8 to 100.4 minutes after Dobbs. Here is the confirmed data on state bans, out-of-state travel volume, clinic closures, and the share of care delivered by telehealth.

She had already driven four hours when she sat down in my exam room. A missed period, a positive test at a rural pharmacy, and a state law that left no in-state option for the care she was requesting. She had taken a day unpaid, borrowed a car, and still faced a second appointment the next morning because the clinic required an ultrasound and a waiting period on separate days. What she wanted was not a policy lecture. She wanted to know whether the delay had already changed what procedures she could get.
That conversation is now routine for clinicians who practice near state lines. Distance is how many patients experience abortion law: hours in a car, missed wages, childcare arranged twice, and a gestational clock that keeps running while they drive.
The data that followed the June 2022 Dobbs v. Jackson Women's Health Organization decision quantify that shift. Mean travel time to the nearest facility roughly tripled in the first post-ruling spatial analysis. Out-of-state patient volume more than doubled relative to 2020. Clinic maps emptied in ban states. Telehealth medication abortion filled much of the gap, but not all of it, and not for everyone. This article gathers the primary figures on travel times, ban counts, interstate volume, clinic closures, and telehealth share.
mean travel time to the nearest U.S. abortion facility in the post-Dobbs spatial model, up from 27.8 minutes before the ruling.
Rader et al., JAMA, 2022
| Measure | Pre-Dobbs (2021 facilities) | Post-Dobbs model (Sep 2022 bans) |
|---|---|---|
| Median travel time | 10.9 minutes | 17.0 minutes |
| Mean travel time | 27.8 minutes | 100.4 minutes |
| Females 15-44 living >60 min from a facility | 14.6% | 33.3% |
| Active facilities in model | 749 | 671 |
Source: Rader B et al. Estimated travel time and spatial access to abortion facilities in the US before and after the Dobbs v Jackson Women's Health decision. JAMA. 2022;328(20):2041-2047. Post-Dobbs estimates simulate closure of facilities in 15 states with total or 6-week bans as of September 30, 2022.
| Year | Out-of-state travelers |
|---|---|
| 2020 | 81000 |
| 2023 | 169000 |
| 2024 | 154000 |
| 2025 | 142000 |
Source: Guttmacher Institute Monthly Abortion Provision Study and March 2026 fact sheet. 2023 is the post-Dobbs peak; 2025 remains roughly 1.75 times the 2020 volume.
The cleanest before-and-after travel numbers still come from a 2022 JAMA spatial analysis by Rader, Upadhyay, Sehgal, Reis, Brownstein and Hswen. Using census-tract centroids for roughly 63.7 million females aged 15-44 in the contiguous United States, and facility locations from the Advancing New Standards in Reproductive Health database, they estimated surface travel time under two conditions: every facility active in 2021, and a post-ruling model treating facilities in 15 states with total or 6-week bans as closed as of September 30, 2022.
The pre-Dobbs median was 10.9 minutes (IQR 4.3-32.4). The mean was 27.8 minutes (SD 42.0). After the modeled closures, the median rose to 17.0 minutes (IQR 4.9-124.5) and the mean to 100.4 minutes (SD 161.5). That mean is the number most people should remember: average travel time more than tripled under the early ban map. The share of reproductive-age females living more than an hour from care rose from 14.6% to 33.3% (P < .001), about one in three once those bans were treated as binding.
Distance in miles tells the same story. A 2025 NBER working paper by Dench, Myers and Pineda-Torres, using the Myers Abortion Facility Database, put the population-weighted average distance at 24.7 miles nationally before Dobbs and 86.6 miles after. In total-ban states the jump was far larger: from 46.8 miles to 279.7 miles for the 34.3 million women of childbearing age living there. Non-ban states barely moved (16.9 to 17.4 miles). The national average hides two nearly separate maps of access.
Limits matter. The JAMA post-Dobbs arm was a simulation of the late-September 2022 ban map, not a GPS track of every patient. It excluded Alaska and Hawaii, assumed efficient ground travel, and did not model appointment scarcity or waiting periods. It also could not foresee later reopenings or mail-order medication abortion. As a first-order measure of how fast facility access collapsed in ban states, it has held up against later work.
Travel distance only makes sense against the legal map that produces it. According to KFF's January 2026 key-facts brief, abortion has been banned in 13 states since the 2022 ruling, and another 6 states have implemented early gestational limits between 6 and 12 weeks. Most remaining states allow abortion to around fetal viability, generally near 24 weeks.
Guttmacher's June 2026 state-policy tracker reaches the same ban count with a slightly different taxonomy: 13 total bans, 28 states with gestational-duration bans, and 9 states plus the District of Columbia with no gestational limit. Of the gestational bans, 7 apply at or before 18 weeks and 21 apply later. A 6-week ban is both an "early limit" in news coverage and a gestational-duration ban in Guttmacher's table.
Exceptions exist on paper in nearly every ban state for life-threatening situations; some add rape, incest, or lethal fetal anomaly language. KFF notes that eight ban states still lack rape or incest exceptions and six lack a health exception for the pregnant person. Statutory text and the practical ability to document an exception are not the same thing. Delay while counsel interprets a statute is itself gestational progression. Policy also moves: Florida went from a 15-week limit to a 6-week ban in May 2024, after which Guttmacher reported out-of-state travel nearly tripled among Floridians; Missouri went from a total ban to three operating clinics by December 2025 after a voter-approved amendment. Anyone quoting a ban count should stamp the date on it.
Interstate travel is the visible consequence of those bans. Guttmacher's Monthly Abortion Provision Study remains the primary national source for patient origin. In 2020, before Dobbs, about 81,000 people obtained a clinician-provided abortion by crossing a state line, nearly one in ten patients even under Roe. Travel then surged. More than 169,000 people traveled out of state in 2023 (16% of U.S. abortions that year). Volume eased to 154,000 in 2024 and about 142,000 in 2025, when 13% of patients still left their home state.
That decline is real and incomplete. 2025 travel remained about 1.75 times the 2020 baseline. Among people living in states with total, six-, or twelve-week bans, Guttmacher's July 2026 travel release found that 98,000 traveled out of state in 2025 while 142,000 in those same restriction categories accessed care via telehealth. Telehealth is absorbing a growing share of what used to require a car, which is why travel can fall while total incidence holds roughly steady.
Destination states cluster along ban borders. KFF's synthesis of Guttmacher data repeatedly lists Illinois, North Carolina, Kansas and New Mexico among the largest receivers. Guttmacher's 2025 full-year estimates put Illinois alone at roughly 32,000 abortions for out-of-state residents, nearly a quarter of national interstate volume. Those clinics absorb extra patients and longer gestational ages, because travel itself consumes days of pregnancy.
| Time point | Clinics | Notes |
|---|---|---|
| 2020 | 807 | Last full pre-Dobbs clinic benchmark |
| 100 days post-Dobbs (2022) | −66 | Clinics in 15 states stopped offering abortion |
| March 2024 | 765 | Guttmacher clinic census |
| End of 2025 | 753 | 2% decline from March 2024; 7% below 2020 |
Sources: Guttmacher Institute clinic reports (2020-2025 census; 100-days post-Roe analysis, October 2022). Ban states had 62 clinics in 2020 and zero providing abortion care as of December 2025.
Facility count is the infrastructure underneath travel time. Within 100 days of the June 24, 2022 decision, Guttmacher documented that at least 66 clinics across 15 states had stopped offering abortion care. That was the first shock, concentrated in trigger-ban states.
The longer arc is a net national loss with local churn. Guttmacher's clinic census put brick-and-mortar abortion clinics at 807 in 2020, 765 in March 2024, and 753 at the end of 2025: a 2% drop from 2024 and 7% from 2020. As of December 2025, the 13 total-ban states had no clinics providing abortion care; those states had 62 in 2020. In the 37 states and D.C. without total bans, clinic counts were slightly higher than in 2020 (+8, about 1%). The national decline is almost entirely the ban-state wipeout plus modest net loss in access states.
Recent losses in protective states still matter for capacity. Between March 2024 and December 2025, New York lost eight clinics, Florida four, Michigan three, and Illinois and California two each; Massachusetts gained six. A stable national total can still mean longer waits in Chicago or Albuquerque if destination clinics close while ban-state patients keep arriving. Online-only virtual clinics (telehealth medication abortion without a patient-facing site) accounted for 12% of clinician-provided abortions in 2023, 20% in 2024, and 24% in 2025, per Guttmacher's March 2026 fact sheet. A county with zero clinics can still have residents receiving clinician-provided care if shield-law telehealth reaches them. Procedural care and later gestational ages still require a physical facility, which is why clinic maps have not become irrelevant.
Medication abortion is now the majority method. Guttmacher's Monthly Abortion Provision Study found that medication abortions accounted for 63% of clinician-provided U.S. abortions in 2023, up from 53% in 2020. The Institute's March 2026 fact sheet reports a related 2023 figure of 65% and notes wide state variation in non-ban jurisdictions, from 44% in Washington, D.C., and 46% in Ohio to 84% in Montana and 95% in Wyoming. Those estimates exclude self-managed abortions outside the formal system.
Telehealth is the channel that turned medication abortion into a distance workaround. Society of Family Planning's #WeCount project reported that the telehealth share of abortions rose from 5% in April-June 2022 to 25% by the end of December 2024. That is one in four abortions delivered remotely. Guttmacher's virtual-clinic series (12% → 20% → 24% from 2023 to 2025) tracks the same direction with a definition focused on online-only providers.
Shield laws are the legal infrastructure behind cross-border telehealth. Providers in protective states can mail medication abortion pills to patients in ban states. Guttmacher's 2025 travel analysis estimated that roughly 42,000 Texans obtained telehealth abortions under shield laws in 2025, up from about 12,400 in 2023, while Texans traveling out of state fell from nearly 34,000 to about 23,000. That is substitution: more pills by mail, fewer road trips, not necessarily fewer abortions overall.
National clinician-provided incidence has been high, not low, after the ruling. Guttmacher estimated 1,058,820 clinician-provided abortions in 2023, 1,124,000 in 2024, and 1,126,000 in 2025: a 21% increase from 2020. Total volume rose even as large regions lost every local clinic. Travel, telehealth, shield laws, and expanded capacity in access states are the usual explanations. Self-managed abortion outside clinical systems remains the large uncounted piece and sits outside those totals.
When a patient has already spent a day on the road, every additional administrative delay is clinical time. Gestational age does not freeze for a waiting period. The statistics on mean travel time are abstract until you are the person deciding whether she can still be offered the method she expected when she left home.
Travel burden is not evenly distributed. In the JAMA analysis, census tracts more than 60 minutes from a post-Dobbs facility already had higher uninsurance, lower income, and lower educational attainment than tracts within an hour. The people least able to take two unpaid days off were the ones most likely to need them. Stratified results also showed large percentage-point increases in the share of Hispanic and Black reproductive-age females living beyond a one-hour drive. That pattern sits on top of long-standing disparities described in our reviews of preventable maternal deaths and healthcare access disparities among U.S. women: the South and rural Midwest lose specialty reproductive care first.
Maternity care deserts compound the problem. Counties without obstetric services are often the same counties without an abortion facility, a pattern covered in our work on maternity care deserts and provider shortages. When the nearest hospital no longer offers obstetric or abortion care, patients leave the county or do not get care at all.
Cost is the quiet partner of miles. Even before accounting for travel, 53% of people obtaining clinician-provided abortions in the 2021-2022 Abortion Patient Survey paid out of pocket, and 41% had incomes below the federal poverty level, per Guttmacher. Travel adds lodging, fuel, and lost wages. A medication abortion that cannot be mailed still requires a trip many households cannot finance on short notice.
Most abortions occur early. Drawing on CDC abortion surveillance for 2022, Guttmacher reports that 40% of abortions occurred at six weeks' gestation or earlier, 53% at 7-13 weeks, and 7% at 14 weeks or later. That means 93% fell in the first trimester among reporting areas. A multi-day travel delay is not a minor inconvenience. A patient who would have been at 8 weeks with local access can arrive at 10 or 11 weeks after travel and a mandatory wait, and the method mix and cost change with each week.
Clinicians outside ban states absorb higher gestational ages at presentation and more patients who need procedural rather than medication care. Clinicians inside ban states counsel about travel and telehealth they cannot provide, manage pregnancy emergencies under statutes written for political rather than clinical clarity, and navigate miscarriage-care ambiguities when the same medications and procedures are restricted. Our overview of miscarriage and pregnancy loss statistics intersects this beat because the clinical tools overlap even when the indication does not.
Prevention remains part of the same system. Barriers to abortion care often travel with barriers to contraception. Method access and Title X capacity are covered in our contraception access and unintended pregnancy statistics. For cycle tracking while decisions are still open, the period calculator, ovulation calculator, and late period tool are practical starting points, not substitutes for clinical care.
The data leave one clear point. National abortion totals did not collapse after 2022. What collapsed was local access in ban states, replaced by longer drives, interstate clinic congestion, and a telehealth channel that works well for early medication abortion and poorly for everyone else. Mean travel time of 100.4 minutes is a national average that softens the lived experience in Louisiana or the Texas Panhandle, where the relevant number is closer to a full workday each way. When you cite one figure from this page, name the geography it describes.
In a 2022 JAMA spatial analysis, mean travel time to the nearest facility rose from 27.8 minutes before Dobbs to 100.4 minutes under a post-ruling ban model; the median rose from 10.9 to 17.0 minutes. A 2025 NBER working paper using facility distance data found average miles rose from 24.7 to 86.6 nationally, and from 46.8 to 279.7 miles in total-ban states.
KFF reports that since the 2022 Dobbs ruling, abortion has been banned in 13 states, with another 6 states enforcing early gestational limits between 6 and 12 weeks. Guttmacher's June 2026 policy tracker likewise lists 13 total bans, plus 28 states with some form of gestational-duration limit and 9 states plus D.C. with no gestational limit.
According to Guttmacher, about 142,000 people crossed state lines for clinician-provided abortion care in 2025, or 13% of patients. That is down from more than 169,000 in 2023 and 154,000 in 2024, but still well above the 81,000 who traveled in 2020.
Medication abortion accounted for 63% of clinician-provided U.S. abortions in 2023, up from 53% in 2020, per Guttmacher. Online-only virtual clinics provided 24% of clinician-provided abortions in 2025. Society of Family Planning's #WeCount project found telehealth rose from 5% of abortions in April-June 2022 to 25% by the end of 2024.
Guttmacher found that at least 66 clinics across 15 states stopped offering abortion care within 100 days of the ruling. By the end of 2025 there were 753 brick-and-mortar abortion clinics nationally, down from 765 in March 2024 and 807 in 2020. The 13 total-ban states had zero clinics providing abortion care in December 2025, versus 62 clinics in those states in 2020.
No. Guttmacher estimates 1,126,000 clinician-provided abortions in 2025, essentially unchanged from 1,124,000 in 2024 and 21% higher than 2020. National volume rose even as ban-state clinic maps emptied. Interstate travel, telehealth, shield-law provision, and capacity growth in access states account for much of that shift. Self-managed abortions outside clinical systems are not included in those totals.
Journalists, researchers and educators are welcome to quote these figures. Please credit Women's Health Association and link to this page so readers can reach the underlying sources.
Women's Health Association. (2026, August 10). Abortion access and travel distance statistics: how far U.S. patients travel after Dobbs. Retrieved from https://www.womenshealthassoc.com/insights/abortion-access-travel-distance-statistics
Published 2026, August 10
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

41.6% of U.S. pregnancies were unintended in 2019, and more than 19 million women who need publicly funded contraception live in contraceptive deserts. Here is the latest data on method use, cost, OTC pills, failure rates, and Title X capacity.

Nearly 1 in 3 U.S. women track fertility or periods digitally, yet audits find most popular women's mHealth apps share data with third parties. Primary figures on usage, privacy audits, prediction accuracy, FTC actions, and user trust.

Nearly 1 in 4 U.S. teens still struggle to afford period products, and 64% of low-income women in a landmark St. Louis study could not buy supplies in the prior year. Here are the prevalence, absenteeism, tax, and free-product figures reporters quote.
Join 250,000+ women receiving our weekly breakdown of new research, policy changes, and health tools.